Clinical Evidence

Significantly Improved Outcomes in Hospitalized Heart Failure:

Heart Failure Outcomes with Volume-Guided Management.

John E. Strobeck, Jonathan Feldschuh and Wayne Miller
JACC: Heart Failure
Volume 6, Issue 11, November 2018
DOI: 10.1016/j.jchf.2018.06.017

Extremely Cost-Effective Improvement in Patient Life Span in Hospitalized Heart Failure:

Cost-Effectiveness Analysis of Early Blood Volume-Guided Management in Hospitalized Heart Failure.

John E. Strobeck, Jonathan Feldschuh, Brent A. Williams and Wayne L. Miller
Presented at HFSA 2020 Virtual Conference

Lower ICU Mortality:

A prospective randomized trial using blood volume analysis in addition to pulmonary artery catheter, compared with pulmonary artery catheter alone, to guide shock resuscitation in critically ill surgical patients.

Yu M, Pei K, Moran S, Edwards KD, Domingo S, Steinemann S, Ghows M, Takiguchi S, Tan A, Lurie F, Takanishi D Jr.
Shock. 2011 Mar;35(3):220-8. doi: 10.1097/SHK.0b013e3181fc9178.

Blood Volume Heterogeneity in Syncope:

Blood volume measurement as a tool in diagnosing syncope.

Fouad-Tarazi F1, Calcatti J, Christian R, Armstrong R, Depaul M.
Am J Med Sci. 2007 Jul;334(1):53-6.

Quantifying Surgical Blood Loss:

Measurement of Blood Loss in Cardiac Surgery: Still Too Much.

Nelson M, Green J, Spiess B, Kasirajan V, Nicolato P, Liu H, Meshkin RS
Ann Thorac Surg. 2018 Apr;105(4):1176-1181. doi: 10.1016/j.athoracsur.2017.11.023. Epub 2018 Mar 3

Understanding the Heterogeneity in Volume Overload

Understanding the Heterogeneity in Volume Overload and Fluid Distribution in Decompensated Heart Failure Is Key to Optimal Volume Management

Wayne L. Miller and Brian P. Mullen
Journal of the American College of Cardiology
Vol. 2, No.3, June 2014

Cardiology

Clinical Evidence Nuclear Medicine

Clinical Evidence Hypertension and Syncope

Clinical Evidence Intensive and Critical Care Medicine

Clinical Evidence Surgery and Anesthesiology

Chronic Fatigue Syndrome

Abstracts

Additional References

Partner With the Dedicated Leader in BVA

As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.

Volume is Vital. End the Debate With Daxor.

Call us at 865-425-0555.

 

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.

Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 865-425-0555 | Fax: 516-828-4772
info@daxor.com | daxor.com

ISO 13485 Certified

Made in the USA.

COPYRIGHT 2021 © DAXOR CORPORATION – ALL RIGHTS RESERVED.